Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori.
Rev Esp Enferm Dig
; 114(2): 89-95, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-33947195
Full text:
1
Database:
MEDLINE
Main subject:
Helicobacter pylori
/
Helicobacter Infections
/
Probiotics
/
Limosilactobacillus reuteri
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Rev Esp Enferm Dig
Journal subject:
GASTROENTEROLOGIA
Year:
2022
Type:
Article